Baxter Recalls Two Lots of IntraVia
Two lots of empty intravenous fluid bags were voluntarily recalled because of the presence of particulates.
Baxter announced on Oct. 22, 2014 that it was voluntarily recalling two lots of IntraVia containers in the US and Canada because of complaints received of particulate matter found inside the fluid path.
IntraVia containers have PVC ports and a sterile fluid path through which intravenous solution travels. Any particulate matter flowing through these containers could cause serious health consequences, Baxter said in a press release.
Affected lots were distributed to customers between Apr. 26, 2013 and June 20, 2013; and between Nov. 27, 2013 and Mar. 10, 2014. Recalled product can be returned for credit to Baxter, and the company encourages patients and healthcare providers to report any adverse events related to the recall.
Source:
FDA
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.
